Netherlands-based research team from the Maastricht University Medical Center, in collaboration with Eindhoven University of Technology and MicroSure, has created and successfully tested on humans the first robot, specifically designed for supermicrosurgery MUSA.

In the article “First-in-human robotic supermicrosurgery using a dedicated microsurgical robot for treating breast cancer-related lymphedema: a randomized pilot trial” published in Nature on February 11, scientists have reported the successful trial and the first robotic system to tackle reconstructive supermicrosurgery MUSA’s feasibility.

With robotic system MUSA, surgeons were able to reconnect vessels with diameters between 0.3 and 0.8 millimetres, which was previously neither possible by robots, nor by humans, due to limitations is “precision and dexterity of the human hands”.

MUSA’s testing involved 20 randomly selected patients with breast-cancer related lymphedema, that requires reconstruction of the blood vessels. All patients have shown improvements and responded positively to the robotic treatment.

As Future Time previously reported, this month Rutgers-led medical research team has also found a way to automate blood testing.

Image credit: MUSA

Follow us on Facebook, Twitter, Telegram, or Youtube!